Back to Awarded Treatment Trials
Awarded Trial: 02-STN-006
Grant ID
02-STN-006
Illness
Schizophrenia
Primary Drug/Intervention
Hydroxychloroquine
Primary Dosage
200mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Desta
Sample Size
61
Duration of Study Period for Each Subject
20 weeks
Outcome Measurements
PANSS
Results
In a trial of 61 patients this antimalarial drug failed to show beneficial effects.
Publication
Desta M, Tadesse A, Gebre N, Barci BM, Torrey EF, Knable MB. Controlled trial of hydroxychloroquine in schizophrenia. J Clin Psychopharmacol. 2002 Oct;22(5):507-10.
Link
http://www.ncbi.nlm.nih.gov/pubmed/12352275
PI Name
Menelik Desta
Degree
MD
Center
N/A
Institution
Amanuel Hospital
Address
PO Box 1971
City or Town
Addis Ababa
State or Province
N/A
Zip or Postal Code
N/A
Country
Ethiopia
Email Address
menelikdesta@hotmail.com